References
- WilhelmSMCarterCTangLBAY 43-9006 exhibits broad spectrum oral anti-tumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisCan Res2004641970997109
- WilhelmSCarterCLynchMDiscovery and development of sorafenib: a multikinase inhibitor for treating cancerNat Rev Drug Discov200651083584417016424
- MoriSCortesJKantarjianHZhangWAndreefMRavandiFPotential role of sorafenib in the treatment of acute myeloid leukemiaLeuk Lymphoma200849122246225519052971
- RavandiFCortesJEJoneDPhase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemiaJ Clin Oncol201028111856186220212254
- LathiaCLettieriJCihonFGallentineMRadtkeMSundaresanPLack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokineticsCancer Chemother Pharmacol200657568569216133532
- LiYCDongLJiaAChangXMXueHPreparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenizationSouth Med Univ2006265541544
- ChenHChangXDuDPodophyllotoxin-loaded solid lipid nanoparticles for epidermal targetingJ Control Release2006110229630616325954
- LiuJHuWChenHNiQXuHYangXIsotretinoin-loaded solid lipid nanoparticles with skin targeting for topical deliveryInt J Pharm2007328219119516978810
- BlanchetBBillemontBCramardJValidation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practiceJ Pharm Biomed Anal20094941109111419278805
- AfifySRappURHoggerPValidation of a liquid chromatography assay for quantification of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serumJ Chromatogr B Analyt Technol Biomed Life Sci2004809199103
- ServiceRFNanomaterials show signs of toxicityScience2003300561724312690169
- HandyRDHenryTBScownTMJohnstonBDTylerCRManufactured nanoparticles: their uptake and effects on fish-a mechanistic analysisEcotoxicology200817539640918408995
- ChenJFZhangDRZhangXSXingJPreparation and material phase analysis of solid lipid nanoparticles loading matrineJ Chin Pharm2005364214217
- LiuJGongTWangCGZhongZZhangZSolid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterizationInt J Pharm20073401–215316217428627
- ZhuSSNew Formulation of DrugBeijing, ChinaChemical Industry Press2003435436
- KuriharaAShibayamaYMizotaAEnhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in micePharm Res19961323053108932454
- HancockBCZografiGCharacteristics and significance of the amorphous state in pharmaceutical systemsJ Pharm Sci19978611129002452
- QinSKGongXLProgress on sorafenib therapy for primary hepatic carcinomaChin Clin Oncol2008131210571068